Armistice Capital, LLC Citius Pharmaceuticals, Inc. Transaction History

Armistice Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.48 - $1.02 $1.38 Million - $2.94 Million	-2,880,000 Reduced 28.36%	7,276,000 $3.64 Million
Q2 2024 Aug 14, 2024	BUY	$0.58 - $1.03 $5.89 Million - $10.5 Million	10,156,000 New	10,156,000 $5.89 Million
Q4 2019 Feb 14, 2020	SELL	$0.42 - $1.15 $922,901 - $2.53 Million	-2,197,385 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.72 - $1.38 $1.58 Million - $3.03 Million	2,197,385 New	2,197,385 $2.47 Million
Q1 2019 May 15, 2019	SELL	$0.86 - $1.53 $635,050 - $1.13 Million	-738,431 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.99 - $1.89 $673,200 - $1.29 Million	680,000 Added 1163.77%	738,431 $768,000
Q3 2018 Nov 14, 2018	BUY	$1.14 - $3.09 $66,611 - $180,551	58,431 New	58,431 $100,000

2.04M

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $229M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.